LFVN | tickerfilter.com

Fundamental analysis

31%

Profitability 37%

Dept financing 12%

Liquidity 49%

Performance 26%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

14.63%

1 Month

2.80%

3 Months

-20.47%

6 Months

-44.03%

1 Year

-61.39%

2 Year

-28.23%

Key data

Stock price

$4.78

P/E Ratio

9.95

DAY RANGE

$4.58 - $4.81

EPS

$0.63

52 WEEK RANGE

$3.90 - $15.00

52 WEEK CHANGE

-$61.39

MARKET CAP

78.239 M

YIELD

2.84%

SHARES OUTSTANDING

12.793 M

DIVIDEND

$0.045

EX-DIVIDEND DATE

03-02-2026

NEXT EARNINGS DATE

05-01-2025

BETA

-0.96

PUBLIC FLOAT

AVERAGE 10 VOLUME

$136,208

AVERAGE 30 VOLUME

$99,157

Company detail

CEO: Steven R. Fife
Region: US
Website: lifevantage.com
Employees: 260
IPO year: 2004

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, and Singapore.

LFVN - Lifevantage Corp